Loading insider details...
Beta
Latest Form 4 (Sep 24, 2026): Sale of 27,612 SKYE shares, $45.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | Skye Bioscience, Inc. (SKYE) | Sale | 27,612 | $45.6K |
| Sep 18, 2026 | Skye Bioscience, Inc. (SKYE) | Sale | 32,607 | $62.3K |
| Aug 31, 2026 | Camp4 Therapeutics Corp (CAMP) | Sale | 400,000 | $1.62M |
| Aug 26, 2026 | Camp4 Therapeutics Corp (CAMP) | Sale | 10 | $45.00 |
| Aug 21, 2026 | Camp4 Therapeutics Corp (CAMP) | Sale | 45,147 | $214.9K |
| Aug 20, 2026 | Skye Bioscience, Inc. (SKYE) | Sale | 45,090 | $17.1K |
| Aug 12, 2026 | Latigo Biotherapeutics, Inc. (LTGO) | Conversion | 4,975,543 | n/a |
| Aug 10, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 10,494 | $73.5K |
| Aug 5, 2026 | Camp4 Therapeutics Corp (CAMP) | Grant/Award | 3,179,558 | $4.86M |
| Aug 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 114,756 | $795.3K |